Why this New York hedge fund manager sees opportunity in European stocks

Influential New York-hedge fund manager Ricky Sandler will turn to Europe for his next stock pick.
Eminence Capital founder Ricky Sandler in Sydney. Picture: John Feder‍

David Rogers

Why this New York hedge fund manager sees opportunity in European stocks

November 6, 2024
Influential New York-hedge fund manager Ricky Sandler will turn to Europe for his next stock pick.
Read Transcript

It has been a great year for stocks, particularly US mega-caps, driven by the AI boom.
 
But influential New York-hedge fund manager Ricky Sandler will turn to Europe for his next stock pick at the upcoming prestigious Sohn Hearts & Minds conference this year.
 
US mega-caps exposed to the AI theme have left other stocks in their wake in the past 12 months.
 
The so-called “Magnificent 7” index of the biggest US tech stocks has soared 50 per cent, with Nvidia up more than 200 per cent. A 33 per cent rise in the S&P 500 over the past 12 months has also been stronger-than-expected US economic growth. And the Federal Reserve’s success in lowering inflation gives substantial room for interest rate cuts if needed, underpinning the economic growth outlook.
 
But the AI theme, the economic outlook and the Fed’s ability to cut rates from here are now well understood and substantially reflected in the valuations of the tech giants and the US stock market, according to Sandler, the founder and chief executive of $US7bn ($11bn) Eminence Capital.
 
That leads him to look for opportunities outside the US and the mega-cap tech stocks.
 
“I think the things that you would have worried about a year ago have turned out better in terms of actual performance,” Mr Sandler told The Australian.
 
“The economy has been surprisingly resilient and inflation has come down considerably.
 
“We could even look forward and say we now have a wealth effect in housing and equities that could help the consumer. “Oil prices have come down, and gas prices have come down a bit.
 
Overall, Sandler thinks the outlook for stocks is “pretty solid.”
 
But valuations are high and sentiment is fairly positive, so “the positives are fairly well known.”
 
In that background, Eminence Capital’s net exposure to stocks reflects a “good backdrop of a solid economy with the Fed on your side, offset by high valuation and sentiment that’s positive too.”
 
But Sandler says it’s also an environment where he’s “comfortable taking a lot of stock-picking risk”, in large and mid-caps – as opposed to mega caps – more so outside the US market.
 
“I think the biggest sort of view that I have is that the market should broaden out here, that we should go beyond the mag seven now, and as we get out to more companies below the surface,” he says. “It doesn’t necessarily have to be small caps, but secondary companies.”
 
“So companies below mega cap – anything between $US2bn and $US50bn – have generally lagged behind. The broader market has lagged behind, so the rally should broaden out.
 
“So, I think it’s a good time to take some stock-picking risk here.”
 
Sandler quickly emerged on the radar of a number of Australian investors as the fund boss delivered one of the top performing stock picks at the 2023 Sohn Hearts & Minds investment conference.
 
For players like Sander, who has about a third of the funds he runs under a short strategy, the real opportunities are in individual stocks rather than the broad market. And a big shift in the drivers of shares over the past two decades has delivered significant opportunity.
 
Most estimates of the US market have passive funds sitting with ETFs or index trackers at around 18-20 per cent of shareholdings. In some companies, it can reach as much as 50 per cent.
 
These days a US stock with a $US30bn market capitalisation, is relatively small versus the mega-caps, and can get “washed-around and miss-priced because it’s not as liquid as the big stuff,” Sandler adds.
 
“So I’d say that’s another theme of ours, that the market should broaden out here, and there’s good opportunity below the surface, and I think good opportunity, even in Europe.
 
“I will tease you and say that the company I’m going to pitch is not a US company.”
 
That only narrows it down to about 10,000 companies, but is indicative of Sandler’s thinking about the US market after such a strong and narrowly-led rise in the past 12 months.
 
“At a big picture level, we aren’t making a call on the market,” Sandler said.
 
“We don’t want to be negative, we don’t want to be overly positive, but we think we can take a lot of risk in picking individual alpha-generating stocks.”
 
While the macroeconomic backdrop doesn’t show any big problems in his view, Sandler wants his portfolio to reflect the fact that sentiment is positive and valuations are high.
 
After stripping out the Magnificent 7 from the S&P 500, it isn’t particularly expensive.
 
The S&P 500 trades around 21.7 times versus its decade average of about 17.5 times.
 
But the equal weight version of the index now trades of a 12-month forward PE multiple of about 17.7 times, versus a decade average near 17 times.
 
“I’d rather look in the companies, below the mega caps, in the US and in Europe,” Sandler says.
 
“There have been a lot of passive flows into the S&P 500 and everyone’s done great for the last 10 years. It’s been a great index. And so everyone that’s looking backwards, like ‘just keep doing that because it’s worked’. And while I don’t want to sit here and say ‘short that’, I think that you want to start to look at other places where less picked over than just barking the S&P 500 index.
 
Donald Trump looked to be on his way to win the US election as of Wednesday, boosting US stock futures, the US dollar, Bitcoin and US bond yields, while slamming the Mexican Peso, the Aussie dollar and copper prices. However, Sandler also sees opportunities in China.
 
“We’re more positive than average on China and that’s not a statement that I know what the government’s going to do and that the economy is going to recover,” he said.
 
“That is more a statement about the fact that nobody’s talking about China, nobody cares, they think it’s kind of uninvestable. But we would say no, there are some interesting things to do there.
 
While wary of Chinese stocks that could be hit by US tariffs, Eminence Capital has investments in “kind of normal, consumer oriented things, so like Macau casinos.”
 
“So I think there are parts that are more wary of parts where I think we can take the risk.”
 
The 2024 event will explore themes including space, AI, geopolitics, biosciences and investing.
 
This article was originally posted by The Australian here.

Licensed by Copyright Agency. You must not copy this work without permission.

It has been a great year for stocks, particularly US mega-caps, driven by the AI boom.
 
But influential New York-hedge fund manager Ricky Sandler will turn to Europe for his next stock pick at the upcoming prestigious Sohn Hearts & Minds conference this year.
 
US mega-caps exposed to the AI theme have left other stocks in their wake in the past 12 months.
 
The so-called “Magnificent 7” index of the biggest US tech stocks has soared 50 per cent, with Nvidia up more than 200 per cent. A 33 per cent rise in the S&P 500 over the past 12 months has also been stronger-than-expected US economic growth. And the Federal Reserve’s success in lowering inflation gives substantial room for interest rate cuts if needed, underpinning the economic growth outlook.
 
But the AI theme, the economic outlook and the Fed’s ability to cut rates from here are now well understood and substantially reflected in the valuations of the tech giants and the US stock market, according to Sandler, the founder and chief executive of $US7bn ($11bn) Eminence Capital.
 
That leads him to look for opportunities outside the US and the mega-cap tech stocks.
 
“I think the things that you would have worried about a year ago have turned out better in terms of actual performance,” Mr Sandler told The Australian.
 
“The economy has been surprisingly resilient and inflation has come down considerably.
 
“We could even look forward and say we now have a wealth effect in housing and equities that could help the consumer. “Oil prices have come down, and gas prices have come down a bit.
 
Overall, Sandler thinks the outlook for stocks is “pretty solid.”
 
But valuations are high and sentiment is fairly positive, so “the positives are fairly well known.”
 
In that background, Eminence Capital’s net exposure to stocks reflects a “good backdrop of a solid economy with the Fed on your side, offset by high valuation and sentiment that’s positive too.”
 
But Sandler says it’s also an environment where he’s “comfortable taking a lot of stock-picking risk”, in large and mid-caps – as opposed to mega caps – more so outside the US market.
 
“I think the biggest sort of view that I have is that the market should broaden out here, that we should go beyond the mag seven now, and as we get out to more companies below the surface,” he says. “It doesn’t necessarily have to be small caps, but secondary companies.”
 
“So companies below mega cap – anything between $US2bn and $US50bn – have generally lagged behind. The broader market has lagged behind, so the rally should broaden out.
 
“So, I think it’s a good time to take some stock-picking risk here.”
 
Sandler quickly emerged on the radar of a number of Australian investors as the fund boss delivered one of the top performing stock picks at the 2023 Sohn Hearts & Minds investment conference.
 
For players like Sander, who has about a third of the funds he runs under a short strategy, the real opportunities are in individual stocks rather than the broad market. And a big shift in the drivers of shares over the past two decades has delivered significant opportunity.
 
Most estimates of the US market have passive funds sitting with ETFs or index trackers at around 18-20 per cent of shareholdings. In some companies, it can reach as much as 50 per cent.
 
These days a US stock with a $US30bn market capitalisation, is relatively small versus the mega-caps, and can get “washed-around and miss-priced because it’s not as liquid as the big stuff,” Sandler adds.
 
“So I’d say that’s another theme of ours, that the market should broaden out here, and there’s good opportunity below the surface, and I think good opportunity, even in Europe.
 
“I will tease you and say that the company I’m going to pitch is not a US company.”
 
That only narrows it down to about 10,000 companies, but is indicative of Sandler’s thinking about the US market after such a strong and narrowly-led rise in the past 12 months.
 
“At a big picture level, we aren’t making a call on the market,” Sandler said.
 
“We don’t want to be negative, we don’t want to be overly positive, but we think we can take a lot of risk in picking individual alpha-generating stocks.”
 
While the macroeconomic backdrop doesn’t show any big problems in his view, Sandler wants his portfolio to reflect the fact that sentiment is positive and valuations are high.
 
After stripping out the Magnificent 7 from the S&P 500, it isn’t particularly expensive.
 
The S&P 500 trades around 21.7 times versus its decade average of about 17.5 times.
 
But the equal weight version of the index now trades of a 12-month forward PE multiple of about 17.7 times, versus a decade average near 17 times.
 
“I’d rather look in the companies, below the mega caps, in the US and in Europe,” Sandler says.
 
“There have been a lot of passive flows into the S&P 500 and everyone’s done great for the last 10 years. It’s been a great index. And so everyone that’s looking backwards, like ‘just keep doing that because it’s worked’. And while I don’t want to sit here and say ‘short that’, I think that you want to start to look at other places where less picked over than just barking the S&P 500 index.
 
Donald Trump looked to be on his way to win the US election as of Wednesday, boosting US stock futures, the US dollar, Bitcoin and US bond yields, while slamming the Mexican Peso, the Aussie dollar and copper prices. However, Sandler also sees opportunities in China.
 
“We’re more positive than average on China and that’s not a statement that I know what the government’s going to do and that the economy is going to recover,” he said.
 
“That is more a statement about the fact that nobody’s talking about China, nobody cares, they think it’s kind of uninvestable. But we would say no, there are some interesting things to do there.
 
While wary of Chinese stocks that could be hit by US tariffs, Eminence Capital has investments in “kind of normal, consumer oriented things, so like Macau casinos.”
 
“So I think there are parts that are more wary of parts where I think we can take the risk.”
 
The 2024 event will explore themes including space, AI, geopolitics, biosciences and investing.
 
This article was originally posted by The Australian here.

Licensed by Copyright Agency. You must not copy this work without permission.

Disclaimer: This material has been prepared by The Australian, published on Nov 06, 2024. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

facebook
linkedin
All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
January 18, 2023

Claremont Global: Investment Case for Nike

Equity Mates are joined by Head of Claremont Global Bob Desmond to discuss his 2022 conference pick, Nike. In the episode Bob unpacks the key metrics, the bull case and the bear case for Nike.

Read More
January 5, 2023

Why Transurban will always be one step ahead of inflation

Loathed by motorists, but loved by investors. Transurban came under focus when Catherine Allfrey nominated the roads operator as her top pick at the recent Sohn Hearts & Minds Conference.

Read More
November 18, 2022

Behind the mega-themes shaping top stockpickers

These are the mega-themes the smartest minds in the market are now firmly getting behind which they believe can help them deliver outsized profits.

Read More
November 18, 2022

Don’t rush to invest yet, fund manager tells Sohn event

Fund manager turned anti-corruption campaigner Bill Browder is advising investors to hang on to their cash until central banks stop raising interest rates and the cost of living starts to come down.

Read More
November 18, 2022

Fund managers go global for top Sohn conference stock picks over Aussie companies

SH&M had before Friday’s event made more than $40m in collective donations to medical research.

Read More
November 18, 2022

Fundies and billionaires party in Hobart

Two hundred of Australia’s best and brightest money managers, bankers and entrepreneurs toasted the seventh Sohn Hearts and Minds conference at David Walsh’s MONA.

Read More
November 18, 2022

Hearts racing: Rich listers rendezvous for speed-dating style stock picking

A room filled with 700 of the country’s financial luminaries and billionaires is a difficult place to pitch an investment idea but it’s a great place to raise money for charity.

Read More
November 18, 2022

How MONA’s David Walsh shocked our top stock pickers

Professional gambler and arts impresario David Walsh had a brutal message for successful top money managers – you may just be lucky.

Read More
November 18, 2022

Why Sohn’s top stock pickers want investors to play it safe

Top global money managers are telling investors to steer clear of companies that don’t make money and invest instead in unloved but profitable businesses.

Read More
November 17, 2022

Five years on, what are the best Sohn stock picks to date?

Some of the top fund managers in the country will on Friday pitch their best investment ideas to the Sohn Hearts & Minds conference.

Read More
November 17, 2022

Low debt counts for everything, says Perpetual’s Aboud

Perpetual’s top stock picker Anthony Aboud makes his money running against the crowd and this is why property trusts like Charter Hall are sitting right the top his list right now.

Read More
November 17, 2022

Perpetual’s Aboud says bet on balance sheets in turbulent markets

Perpetual’s Anthony Aboud says companies with strong balance sheets will finally be rewarded for their discipline in a time of global market upheaval.

Read More
November 16, 2022

How Gerry Cardinale of RedBird Capital tries to double his money investing in sport

The owner of AC Milan and a host of other soccer, cricket, baseball and ice hockey assets is trying to double his money in the ‘resilient’ asset class.

Read More
November 14, 2022

Think outside the box for green investment opportunities

James Miller, Portfolio Manager at Firetrail Investments, believes investors need to stop seeing the global decarbonisation push as a risk – and start seeing it as an opportunity.

Read More
November 14, 2022

Tim Carleton is backing the Aussie dream all the way

Carleton’s conviction will be on full display on Friday when he makes his third appearance at the Sohn Hearts & Minds Conference, where stock-pickers share their best ideas in the name of medical research.

Read More
December 10, 2024

Professor Jane Butler: Sparking Hope for Spinal Cord Injuries

In this episode of the Hearts & Minds Podcast, we sit down with Professor Jane Butler to discuss her groundbreaking research into spinal cord injuries.

Read More
impact-podcasts
September 24, 2024

Asian Market Potential with Tom Naughton of Prusik

CIO Charlie Lanchester sits down with Tom Naughton, CIO of Prusik Investment Mgmt. Tom shares his investment philosophy, the opportunities and challenges in Asian markets, and how his 2023 conference stock pick, Swire Pacific (0019.HK), delivered an impressive 30% return.

Read More
investing
September 4, 2024

Building Hearts and Minds with Co-Founders Matthew Grounds and Guy Fowler

In this episode, co-founders Matthew Grounds AM and Guy Fowler OAM discuss their journey in building Hearts & Minds and its philanthropic model that has donated over $70 million to medical research.

Read More
investing
June 25, 2024

Navigating the Resource Sector with Jeremy Bond of Terra Capital

In this episode, we chat with Jeremy Bond, Founder of Terra Capital and HM1 Conference Fund Manager. Tune in for insights into the world of resource investments and the exciting opportunities that lie ahead.

Read More
investing
June 11, 2024

Prof. Nadia Badawi on Cerebral Palsy Breakthroughs and Neonatal Care

Dive deep into the groundbreaking work of Professor Nadia Badawi, an internationally recognised neonatologist and expert in Cerebral Palsy.

Read More
impact-podcasts
May 28, 2024

Investment Insights: Rikki Bannan on Top Picks and Trends

Join us for an engaging episode featuring Rikki Bannan, Portfolio Manager of IFM Investors and HM1 Conference Fund Manager. This episode explores Rikki's career journey, investment strategies, and her 2023 conference stock pick, Telix Pharmaceuticals (ASX.TLX).

Read More
investing
December 6, 2023

Peter Cooper talks building and instilling a culture of humility and excellence

In this episode, our guest is the renowned investor, Peter Cooper, founder and Chief Investment Officer of Cooper Investors (Core Fund Manager). A founding supporter of Hearts and Minds, Peter is a staunch advocate of our model and its philanthropic purpose, actively engaging in every facet of Hearts and Minds.

Read More
investing
November 28, 2023

Jun Bei Liu on her high conviction investment strategy

In this episode, HM1 Chief Investment Officer Charlie Lanchester is joined by Jun Bei Liu. Jun Bei is the Portfolio Manager of Tribeca’s Alpha Plus Fund and since taking over managing the Fund, she has quadrupled AUM.

Read More
investing
November 21, 2023

The world of rare genetic disease research

In this episode, we speak to Associate Professor Gina Ravenscroft. Gina is an Associate Professor in Neurogenetics at the Harry Perkins Institute of Medical Research in Perth. Her research interests are in rare genetic diseases, with a particular focus on neurogenetic diseases in babies and children.

Read More
impact-podcasts
November 14, 2023

Learn what makes a high conviction investment and how to avoid short-term noise

In this episode, our Core Fund Manager Magellan shares how they select top stocks for the HM1 portfolio.

Read More
investing
November 7, 2023

Delve into the world of kids critical care and trauma research

In thie episode, we are joined by Dr. Marino Festa, or Rino for short. He is the Medical Director of NSW Kids ECMO Referral Service and a senior specialist in Paediatric Intensive Care at Children’s Hospital at Westmead.

Read More
impact-podcasts
October 31, 2023

Where Regal's Phil King is searching for opportunities

HM1's CIO, Charlie Lanchester, talks to Phil King of Regal Funds about his passion for stocks, his ongoing search for opportunities, and some of the sectors he’s excited by right now. Phil King of Regal Funds, has been a tremendous supporter of Hearts & Minds since the beginning.

Read More
investing
October 24, 2023

Preventing recurrent miscarriages and birth defects

In this episode, CEO Paul Rayson is joined by renowned biomedical researcher Professor Sally Dunwoodie. Prof. Dunwoodie's groundbreaking work has revolutionised clinical practices and enabled genetic diagnostic tests worldwide. In 2017, her team achieved a double breakthrough with the potential to prevent recurrent miscarriages and various birth defects.

Read More
impact-podcasts
October 17, 2023

Nick Griffin on how he finds global winners

In this episode, CIO Charlie Lanchester chats with Nick Griffin, the founding partner and CIO of Munro Partners, one of HM1's Core Fund Managers. They go over his career to date, reflect on the lessons he’s learned, and trace the decisions that led to him starting Munro.

Read More
investing
October 10, 2023

How A/Prof Matt Call is teaching our body to kill cancer

In this episode, CEO Paul Rayson is joined by WEHI’s Associate Professor Matt Call to talk about his incredible research. Matt’s team teaches and trains the body's own immune cells to target and kill cancer cells.

Read More
impact-podcasts

No results found.

Please try a different search keyword or filter.